Today, Sarepta Therapeutics Inc (NASDAQ: SRPT) Takes Center Stage

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

SRPT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $126.87 and fluctuated between $129.19 as its day high and $126.33 as its day low. The current market capitalization of Sarepta Therapeutics Inc is $11.87B. A total of 0.78 million shares were traded on the day, compared to an average of 0.62 shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, SRPT has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 4,508 shares. Over the last 12 months, there were 25 BUYs and 19 SELLs from insiders. Insiders purchased 202,418 shares during that period but sold 28,026.

In the most recent transaction, Barry Richard bought 50,000 shares of SRPT for 78.81 per share on Nov 03. After the transaction, the Director now owns 140,000 company shares. In a previous transaction on Nov 03, INGRAM DOUGLAS S bought 25,225 shares at 79.36 per share. SRPT shares that President & CEO owns now total 390,307.

Among the insiders who bought shares, Chambers Michael Andrew acquired of 9,979 shares on Aug 14 at a per-share price of $109.47. This resulted in the Director holding 246,996 shares of SRPT after the transaction. In another insider transaction, Chambers Michael Andrew bought 23,686 shares at $108.05 per share on Aug 11. Company shares held by the Director now total 237,017.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for SRPT in the last 3 months, the mean price target is $149.80 with high estimates of $224.00 and low estimates of $103.00. In terms of 52-week highs and lows, SRPT has a high of $159.89 and a low of $55.25.

As of this writing, SRPT has an earnings estimate of $0.02 per share for the current quarter. EPS was calculated based on a consensus of 16 estimates, with a high estimate of $0.61 per share and a lower estimate of -$1.03. The company reported an EPS of -$0.27 in the last quarter, which was 84.80% higher than expectations of -$1.78.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SRPT’s latest balance sheet shows that the firm has $2.12B in Cash & Short Term Investments as of fiscal 2021. There were $1.15B in debt and $452.73M in liabilities at the time. Its Book Value Per Share was $8.17, while its Total Shareholder’s Equity was $928.01M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRPT is Buy with a score of 4.52.

Most Popular

Related Posts